Literature DB >> 11200067

Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst.

G Engelich1, M White, K L Hartshorn.   

Abstract

Bacterial superinfections are an important cause of morbidity and mortality during influenza A virus (IAV) epidemics. We demonstrate that incubation with the combination of IAV and Streptococcus pneumoniae caused marked reductions in survival of neutrophils in vitro compared with treatment with control buffer or IAV or S. pneumoniae alone. This cooperative effect was in part mediated by acceleration of neutrophil apoptosis as evidenced by increases in annexin-V binding and caspase-3 activation. However, GM-CSF did not increase survival of neutrophils exposed to IAV and S. pneumoniae. IAV enhanced neutrophil uptake of S. pneumoniae significantly. Furthermore, the combination of IAV and S. pneumoniae caused significantly more hydrogen peroxide production than IAV or S. pneumoniae alone. This increased respiratory burst activity contributed to the diminished neutrophil survival caused by IAV and S. pneumoniae. The NADPH oxidase inhibitor, diphenyleneiodonium, significantly improved survival of neutrophils treated with IAV and S. pneumoniae. These findings may help to explain the increased susceptibility of IAV-infected patients to infections with S. pneumoniae.

Entities:  

Mesh:

Year:  2001        PMID: 11200067

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  37 in total

Review 1.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Influenza virus induces bacterial and nonbacterial otitis media.

Authors:  Kirsty R Short; Dimitri A Diavatopoulos; Ruth Thornton; John Pedersen; Richard A Strugnell; Andrew K Wise; Patrick C Reading; Odilia L Wijburg
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

Review 3.  Postinfluenza bacterial pneumonia: host defenses gone awry.

Authors:  Megan N Ballinger; Theodore J Standiford
Journal:  J Interferon Cytokine Res       Date:  2010-09       Impact factor: 2.607

4.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

5.  Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1.

Authors:  Ben A Croker; Joanne A O'Donnell; Cameron J Nowell; Donald Metcalf; Grant Dewson; Kirsteen J Campbell; Kelly L Rogers; Yifang Hu; Gordon K Smyth; Jian-Guo Zhang; Michael White; Kurt Lackovic; Louise H Cengia; Lorraine A O'Reilly; Philippe Bouillet; Suzanne Cory; Andreas Strasser; Andrew W Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

6.  Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection.

Authors:  Keer Sun; Dennis W Metzger
Journal:  J Immunol       Date:  2014-02-21       Impact factor: 5.422

7.  LL-37 modulates human neutrophil responses to influenza A virus.

Authors:  Shweta Tripathi; Anamika Verma; Eun-Jeong Kim; Mitchell R White; Kevan L Hartshorn
Journal:  J Leukoc Biol       Date:  2014-07-31       Impact factor: 4.962

Review 8.  Secondary bacterial infections in influenza virus infection pathogenesis.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 9.  Role of neutrophils in innate immunity: a systems biology-level approach.

Authors:  Scott D Kobayashi; Frank R DeLeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Nov-Dec

Review 10.  Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.

Authors:  Koenraad F van der Sluijs; Tom van der Poll; René Lutter; Nicole P Juffermans; Marcus J Schultz
Journal:  Crit Care       Date:  2010-04-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.